Continued.
No. | Age/sex/code | Histology | Sitea | Sizeb | Follow-up in months | CGH karyotypea | |
---|---|---|---|---|---|---|---|
Losses | Gains and high-level amplifications | ||||||
51 | 54/m PR10 | Malignant | Jejunum | 15 | Alive, 22 | 1p, 2, 7p, 11, 15, 18, 22 | 4q, 7q, 9p, 12q |
51b | PR11 | Metastases | Abdomen | 1p, 2, 4p, 11, 12p, 13, 15, 17p, 18, 22 | 5q, 7q, 8q, 9p, 21 | ||
51c | PR12 | Metastases | Abdomen | 1p, 2p, 13, 15, 18, 22 | 5q, 10p | ||
52 | 59/m PR13 | Malignant | Small intestine | 20 | DOD, 49 | 1p, 8, 13, 14, 15, 22 | 1q, 2q22–qter, 4p, 5p, 17, 20p |
52b | PR14 | Metastases | Abdomen | 1p, 3pter–q13, 4q, 8, 9pter–q21, 10, 13, 14, 15, 22 | 1q, 2q22–qter, 4p, 5p, 17, 20p | ||
52c | PR15 | Metastases | Abdomen | 1p, 3pter–q13, 4q, 8, 9pter–q21, 13, 14, 15, 22 | 1q, 2q22–qter, 5p, 17, 20p | ||
53 | 62/f PR16 | Malignant | Stomach | 15 | Alive, 60 | 6, 9, 12pter–q22, 14, 22 | 17 |
53b | PR17G5 | Metastases | Abdomen | Alive | 9, 14, 22 | 17q | |
53c | PR18 | Metastases | Abdomen | 9, 14, 22 | 4, 17q, 20 | ||
54 | 59/m PR19G3 | Malignant | Ileum | 12 | DOD, 14 | 13, 14q11–q12 | 5p |
54b | PR20 | Metastases | Liver | 12p, 14 | 5p, 8q | ||
55 | 38/f PR21 | Malignant | Jejunum | 10 | DOD, 59 | 1p, 11q14–qter, 13, 14, 15, 18, 22, X | 1q, 5p, 8 |
55b | PR22 | Metastases | Abdomen | 1p, 15, 18, 22q13 | 1q, X | ||
55c | PR23 | Metastases | Abdomen | 1p, 15, 18, 22q13 | 1q | ||
55d | PR24 | Metastases | Abdomen | 1p, 13, 15, 18, 22 | 1q | ||
56 | 52/f PR33 | Malignant | Small intestine | 10 | DOD, 12 | 1p, 14, 15 | 7, 8, 12q22–qter |
56b | PR34 | Metastases | Abdomen | 1p, 14, 15 | 7, 8, 12q22–qter | ||
57c | PR35 | Metastases | Abdomen | 1p, 14, 15 | 7, 8, 12q22–qter | ||
58 | 61/m PR36 | Malignant | Stomach | 25 | DOD, 19 | 1p, 11, 13, 14, 15 | 2q, 8q23–qter, 17q, X |
58b | PR37 | Metastases | Abdomen | 1p, 9 | 20 | ||
58c | PR38 | Metastases | Abdomen | 1p, 9 | 17q22–qter, 20 | ||
59 | 39/m PR39 | Malignant | Stomach | 20 | DOD, 14 | 4q27–q34, 9, 14, 22 | |
59b | PR40 | Metastases | Abdomen | 4q27–q34, 9, 14, 22 | |||
59c | 33/m PR42 | Metastases | Abdomen | 1p11–p32, 4, 9pter–q33, 14 | 20q13.2–qter | ||
60 | 41/f PR45 | Malignant | Stomach | 6 | Alive, 6 | 1p35–pter, 4, 9, 15, 22 | 5, 8p12–pter, 8q23–qter, 12q14–qter, 13, 18q |
60b | PR46 | Metastases | Abdomen | 1p35–pter, 4, 6q, 9, 14q11–q21, 15, 22 | 5, 8p12–pter, 8q23–qter, 12 (12q22–qter), 13, 18q, 20q | ||
60c | PR47 | Metastases | Abdomen | 1p35–pter, 4, 9, 10, 14, 15, 22 | 5p, 5q32–qter, 8p12–pter, 8q23–qter, 12 (12q22–qter), 13, 20q |
All metastases were intra-abdominal.
Maximum size in cm, high.
High-level amplifications are in bold; NED, no evidence of disease; NA, not available; DOD, died of disease.